Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Q32 Bio (QTTB) Cash from Operations (2017 - 2025)

Q32 Bio (QTTB) has 9 years of Cash from Operations data on record, last reported at 6180000.0 in Q4 2025.

  • For Q4 2025, Cash from Operations rose 45.92% year-over-year to 6180000.0; the TTM value through Dec 2025 reached 33543000.0, up 50.46%, while the annual FY2025 figure was 33543000.0, 50.46% up from the prior year.
  • Cash from Operations reached 6180000.0 in Q4 2025 per QTTB's latest filing, down from 4230000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 15901000.0 in Q3 2023 and bottomed at 30846000.0 in Q2 2022.
  • Average Cash from Operations over 5 years is 17167350.0, with a median of 17036500.0 recorded in 2024.
  • Peak YoY movement for Cash from Operations: soared 163.78% in 2023, then plummeted 222.77% in 2024.
  • A 5-year view of Cash from Operations shows it stood at 30430000.0 in 2021, then rose by 10.62% to 27199000.0 in 2022, then skyrocketed by 60.61% to 10715000.0 in 2023, then decreased by 6.65% to 11428000.0 in 2024, then surged by 45.92% to 6180000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Operations were 6180000.0 in Q4 2025, 4230000.0 in Q3 2025, and 10651000.0 in Q2 2025.